29 C
Vientiane
Friday, May 2, 2025
spot_img
Home Blog Page 673

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment

LONDON, Feb. 4, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: stunning growth shocks the atrial fibrillation market. The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology’s potential to transform the treatment paradigm for atrial fibrillation.  

Cryoablation and radiofrequency (RF) ablation can cause damage to non-targeted tissues, such as the pulmonary vein, esophagus and phenic nerve. As a result, PFA has emerged as an appealing alternative for treating atrial fibrillation, attracting significant investment from companies worldwide. The technology leverages high-voltage, microsecond electrical pulses rather than thermal energy, enabling a safer, faster procedure with higher success rates and reduced recurrence rates. Consequently, electrophysiologists are rapidly switching to PFA and away from RF and cryoablation.

Juliane Ray, General Manager, Medtech, Life Sciences and Healthcare, Clarivate, said: “The evolution of cardiac ablation is at a pivotal moment, with pulsed field ablation emerging as a breakthrough that is reshaping treatment guidelines and expanding patient access worldwide. As clinical evidence continues to build, we are seeing a shift toward ablation as a first-line therapy, reinforcing the need for innovation in mapping, delivery systems, and procedural efficiency. This e-book explores the latest advancements and market dynamics, equipping stakeholders with the insights needed to anticipate the next wave of transformation in cardiac care.”

Andrew Lee, Vice President, Medtech, Life Sciences and Healthcare, Clarivate, said: “The rapid adoption of pulsed field ablation underscores its transformative potential in cardiac care, reshaping the treatment landscape and expanding access for patients worldwide. This e-book provides cardiologists and medical device companies with a comprehensive view of the latest advancements and trends, equipping them with the insights needed to navigate this evolving market. As PFA drives unprecedented growth and innovation, staying informed is crucial for making strategic decisions that align with this dynamic and rapidly expanding sector.”

Anette Boyle, Editor, BioWorld, Clarivate, said: “PFA may be the most significant Medtech advance in cardiology in the last decade – and it has certainly been the most rapidly adopted. With the total number of cardiac ablation procedures for atrial fibrillation expected to double in the next two to three years, major players and start-ups alike are racing to complete clinical trials and gain regulatory approvals. We expect to see brisk M&A in this area as companies lagging in development of their own products seek to leapfrog the competition and secure a slice of this hot market.”

Key updates and the forecast of the global PFA market featured in Pulsed field ablation: stunning growth shocks the atrial fibrillation market, include:

  • Key players: Companies and PFA systems, including FARAPULSE, Affera Sphere-9 and PulseSelect, gained regulatory approvals around the world and even more began clinical trials in 2024. While Johnson & Johnson’s VARIPULSE received FDA approval in November, the company indefinitely paused its limited U.S. rollout to investigate multiple neurovascular events associated with its use in January. Abbott Laboratories, the last of the big four players in the market to gain U.S. marketing authorization, completed enrolment in its VOLT-AF pivotal trial in October and could receive FDA approval as early as mid-2026, with CE mark likely in early 2025.
  • Rapid expansion in international markets: PFA adoption grew exponentially with FDA approvals in the U.S. in late 2023 and early 2024. Mainland China, Japan and Australia all have three approved PFA systems, and the market for PFA in the Asia Pacific region is expected to surpass $1 billion over the next three to five years. China has several domestic manufacturers in the mix, making it a more competitive landscape for global firms. Japan alone could become a $300 million market by 2028.
  • Market value forecast: From a base of $300 million globally in 2023 and 5% of the atrial fibrillation market, Clarivate expects PFA to approach $8 billion in market value and capture more than 70% of the global atrial fibrillation market by 2028.

Pulsed Field Ablation: Stunning Growth Shocks the Atrial Fibrillation Market, offers an in-depth analysis of recent breakthroughs and the transformative potential of PFA technology featuring insights from the editor of BioWorld MedTech, Annette Boyle, and up-to-the-minute analysis from Clarivate’s Medtech experts.

To learn more about the Clarivate e-book, visit here

To track developments in cardiac ablation and other medical technologies on a daily basis, subscribe to BioWorld MedTech, here: BioWorld MedTech: The Daily Medical Technology News Source.

The Electrophysiology Mapping and Ablation Device Market Insights series provides a comprehensive global market view with granular insights into market dynamics in the broader ablation market as well as the game-changing potential of PFA technology. Designed to ensure our customers have the most current and actionable data to guide their strategic decisions and drive progress toward a healthier future, the series draws on the expertise of Clarivate’s Medtech analysts, who leverage proprietary Clarivate Medtech Intelligence data, including Real World Data assets like claims data and PriceTrack. For the latest forecasts for Electrophysiology Mapping and Ablation Device geographical markets, see our Medtech Insights reports, here: Medtech Insights | Clarivate

About BioWorld
With writers and editors stationed around the globe, BioWorld MedTech, published by Clarivate, reports the breaking news and provides key perspective on thousands of innovative medical technologies and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. The BioWorld group of news services (BioWorld, BioWorld Science, BioWorld MedTech and BioWorld Asia) has a long tradition of excellence in journalism. Collectively, the news services have been honored with 70 awards dating back to 1998.

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact:
Luna Ivkovic,
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com

 

Authorities Crack Down on Illegal Forest Activity in Oudomxay

Forest Fires in Oudomxay

In Oudomxay Province, a report has emerged indicating that 674 cases of forest encroachment, forest destruction, and forest fires were recorded in 2024. 

GC Labs strengthens global ties and explores new opportunities at Medlab Middle East 2025

YONGIN, South Korea, Feb. 4, 2025 /PRNewswire/ — GC Labs, a leading clinical laboratory in South Korea, announced the successful completion of the second day of the Medlab Middle East 2025, which is being held at the Dubai World Trade Centre (DWTC), UAE between February 3-6.

An image of GC Labs' booth installed at Medlab Middle East 2025 held at Dubai World Trade Centre (DWTC), UAE
An image of GC Labs’ booth installed at Medlab Middle East 2025 held at Dubai World Trade Centre (DWTC), UAE

GC Labs has participated in the MENA region’s largest medical laboratory exhibition and conference for four consecutive years, leveraging its presence at Medlab to strengthen partnerships while actively exploring global market expansion and new business opportunities.

During the first two days of the exhibition, GC Labs achieved remarkable results, generating strong foot traffic and building connections with potential partners. Located at booth Z4.E49, GC Labs showcased its advanced diagnostic testing services, including tests for Alzheimer’s disease and Heavy metal exposure, tailored to meet the specific needs of the Middle Eastern market.

One of the highlights was GC Labs’ innovative digital pathology consulting service, which provides both primary diagnosis and second opinion. By digitalizing specimen slides, GC Labs enables real-time remote diagnosis and consultations for various pathology cases, significantly improving turnaround time and accuracy. Attendees expressed keen interest in the service, recognizing its potential to streamline workflows and to give partners a competitive edge.

In addition, GC Labs engaged in strategic discussions with its existing partners in the Middle East to foster mutual growth. The discussions focused on optimizing testing processes by integrating Laboratory Information System (LIS) through Application Programming Interfaces (APIs). The transfer of test methodologies was also reviewed, along with plans to expand into new business areas beyond the current test send-out business.

GC Labs officials said, “GC Labs finds the positive response and interest generated during the first two days of Medlab Middle East 2025. Our continued presence at this event underscores our commitment to delivering word-class diagnostic solutions and fostering strong partnerships in the region.”

GC Labs will continue to exhibit at Medlab Middle East 2025 until February 6 at booth Z4.E49.

About GC Labs

GC Labs is a Korea’s leading clinical laboratory which provides clinical and pathology reference testing supported by over 40 years of expertise. GC Labs consists of about 800 medical professionals and carries out over 5,000 test items, ranging from routine tests to highly specialized and esoteric assays. GC Labs provides more than 3,500 clients worldwide with unrivalled quality of tests, which is accredited by multiple regulatory agencies and accrediting organizations, such as the College of American Pathologists (CAP), the Centers for Disease Control and Prevention (CDC) and others. Under the ultimate mission of ‘Pioneering a better healthcare for humankind’, GC Labs makes relentless efforts to give patients the quickest, the most accurate answers for the best outcomes.

For further information, please visit our website www.gclabs.co.kr/eng.

Government Of The Republic Of Botswana And De Beers Conclude Negotiations On Rough Diamond Sales Agreement


HONG KONG SAR – Media OutReach Newswire – 4 February 2025 – The Government of the Republic of Botswana (“GRB”) and De Beers Group (“De Beers”) are pleased to announce the successful conclusion of negotiations focused on establishing a new sales agreement for Debswana’s rough diamond production, as well as extending Debswana’s mining licences beyond 2029. This development is in alignment with the Heads of Terms agreed on September 30, 2023.

Debswana, a 50:50 joint venture between the GRB and De Beers, operates several leading diamond mines in Botswana: Jwaneng, Orapa, Letlhakane, and Damtshaa.

Following the issuance of new mining licences by the appropriate regulatory authorities in Botswana and final governance approvals, both parties look forward to signing and executing the relevant agreements. Until the execution of these new agreements, the terms of the existing agreements will continue to remain in effect.

The GRB and De Beers reaffirm their commitment to their enduring partnership, which has lasted over 50 years. This collaboration is aimed at the responsible recovery, marketing, and sale of diamonds, ensuring the sustainability of the global diamond industry while enhancing the significant fiscal and societal contributions that diamonds provide to Botswana.

The GRB and De Beers remain steadfast in their dedication to fostering a robust and sustainable diamond sector that positively impacts the nation’s economy and supports the welfare of its citizens.

Hashtag: #DeBeersGroup #Debswana





The issuer is solely responsible for the content of this announcement.

About Botswana

Botswana, a thriving democracy, is located in Southern Africa. It is the topmost producer of diamonds by value. Botswana is renowned for the rule of law, including respect for property rights. Heralded for its ease of doing business in the mining sector, it is by no coincidence that it is a premier investment destination for mining.

The Botswana government has placed a strong emphasis on the effective management of its diamond resources, recognizing their pivotal role in the nation’s economic development. By exercising careful oversight and strategic partnerships, Botswana maximizes revenue from diamond sales, strengthen its
position as a key player in the global diamond market and ensuring that these valuable resources drive sustainable socio-economic growth. With a focus on sustainable practices, the government is dedicated to ensuring that the wealth generated from diamond mining contributes significantly to the welfare of its
citizens. Revenue from these sales is strategically reinvested to foster growth, infrastructure development, and social programs, ultimately positioning Botswana as a stable and prosperous socio-economic hub in the region. This commitment underscores the government’s vision of enhancing the livelihoods of its people while promoting overall national prosperity, thereby solidifying Botswana’s reputation as a forward-thinking and resilient nation in the face of global economic challenges.

About De Beers Group

Established in 1888, De Beers Group is the world’s leading diamond company with expertise in the exploration, mining, marketing and retailing of diamonds. Together with its joint venture partners, De Beers Group employs more than 20,000 people across the diamond pipeline and is the world’s largest diamond producer by value, with diamond mining operations in Botswana, Canada, Namibia and South Africa. Innovation sits at the heart of De Beers Group’s strategy as it develops a portfolio of offers that span the diamond value chain, including its jewellery houses, De Beers Jewellers and Forevermark, and other pioneering solutions such as diamond sourcing and traceability initiatives Tracr and GemFair. De Beers Group also provides leading services and technology to the diamond industry in the form of education and laboratory services via De Beers Institute of Diamonds and a wide range of diamond sorting, detection and classification technology systems via De Beers Group Ignite. De Beers Group is committed to ‘,’ a holistic and integrated approach for creating a better future – where safety, human rights and ethical integrity continue to be paramount; where communities thrive and the environment is protected; and where there are equal opportunities for all. De Beers Group is a member of the Anglo-American plc group. For further information, visit .

Democrats Blast Musk as USAID Agency HQ Shutters

Democrats Blast Musk as USAID Agency HQ Shutters
Elon Musk attacked the US Agency for International Development (USAID), calling it a "criminal organization" on February 2, 2025, as US President Donald Trump claimed the agency was "run by radical lunatics" and said he was considering its future. (Photo by ASHRAF SHAZLY / AFP)

By Frankie TAGGART/AFP – The United States government’s giant humanitarian agency closed its headquarters to staff on 3 February amid moves by Elon Musk, the world’s richest person and President Donald Trump’s controversial aide, to seize control in actions decried by critics as “plain illegal.”

Pets found to be ‘Millennials’ best friend’ with the generation depending more on their pets than any other

BRISBANE, Australia, Feb. 4, 2025 /PRNewswire/ — More than 50% of millennial Aussies have a pet for mental health reasons or as a support animal, a new survey has revealed. Rather than being a man’s best friend, pets it seems are these days, millenials’ best friends.

A poll of 1000 Australians from leading pet insurer Budget Direct found more than 71% of millennials (28-37 year olds) said they got their pet for companionship, while close to 40% said they got their pet solely to help improve their mental health.

With millennials seen as being more open about mental health issues and normalising therapy, it’s no wonder they are the generation that depends on their pets the most.

“Like many pet owners, it’s clear that millennials consider their pets as part of their family.  But the fact that almost 15% acquired their pets solely to be their support animal shows how emotionally important they are to this group,” a Budget Direct spokesperson said.

“We share such a special bond with our dogs and cats and this really shows just how much we value companionship. Whether it’s social quality play time with the pet or taking them on walks in the park or beach, there’s no doubt about the happiness and contentment our furry friends provide.”

When delving deeper into the survey, nearly 30% of cat owners were more likely to acquire their pets for mental health reasons compared to 25% of dog owners. But when it comes to pet ownership, more than 60% of Aussies own a dog, compared to 31% who own a cat.

Support animals offer emotional stability to those with conditions like anxiety or depression and their companionship is key to their support rather than having undergone specific training.

Any pet can improve quality of life and provide emotional support, regardless of where they come from–pedigree or rescue pets.

Nearly 30% of respondents said they acquired their oldest or only pet from a shelter, with 19% of those surveyed being gifted their pet.

For the full breakdown and further insights from the Budget Direct Australian Pet Survey visit here.

DISCLAIMER

Insurance is arranged by Auto & General Services Pty Ltd (ABN 61 003 617 909, AFSL 241 411, Registered Office: 13/9 Sherwood Rd, Toowong 4066) on behalf of the insurer, Auto & General Insurance Company Limited ABN 42 111 5 86 353.

Cristiano Ronaldo Life Museum Set to Open in Hong Kong: A Celebration of a Football Legend

Tickets to immersive cultural attraction set to honor football icon’s inspiring career go on sale from 5th February


HONG KONG SAR – Media OutReach Newswire – 4 February 2025 – The highly anticipated Cristiano Ronaldo Life Museum is set to open its doors in July 2025 at K11 Art & Cultural Centre (6F, Kunsthalle), K11 MUSEA in Tsim Sha Tsui. The grand opening will feature several international celebrities, marking a monumental celebration of the football legend’s illustrious career. This state-of-the-art museum celebrates Cristiano Ronaldo’s career and the power of ambition, passion, perseverance and hard work; a beacon of inspiration for fans and visitors.

Cristiano Ronaldo
Cristiano Ronaldo

Featuring state-of-the-art interactive exhibits, rare memorabilia, and motivational storytelling, the Cristiano Ronaldo Museum offers an immersive experience designed to inspire greatness. The Cristiano Ronaldo Museum is designed to be a place where visitors not only celebrate the accomplishments of a global icon but also reflect on their own aspirations. Aimed at empowering youth and dreamers, the museum features motivational content and inspiring quotes to encourage visitors to unlock their full potential. The museum will be the first of its kind in Asia and aims to attract over 12 million visitors to Hong Kong, providing significant exposure for the city as a global tourist destination.

This initiative presents a unique opportunity for Hong Kong to unite and spread happiness throughout the city. The CR7® LIFE Museum will naturally inspire collaborations across Hong Kong’s hospitality sector, food and beverage outlets, retail businesses, tourism agencies, and the MTR. These synergies are expected to foster a collective movement called “HONG KONG UNITED,” encouraging all sectors to embrace and welcome tourists from around the globe. This organic connection aims to create a positive ripple effect, benefiting the entire city.

Tickets for the museum will go on sale on February 5, 2025, coinciding with Cristiano Ronaldo’s birthday, allowing fans worldwide to partake in this historic opening. Early bird ticket buyers will unlock exclusive benefits at merchandise stores, offering unique opportunities to enhance their CR7® LIFE Museum experience.

On February 5, a grand celebration will take place at the K11 MUSEA promenade to honour Cristiano Ronaldo, a global icon whose impact transcends the world of football. As part of this unique event, attendees can expect extraordinary surprises that promise to make the occasion truly unforgettable, reflecting the unparalleled legacy of this legendary figure.

In addition to the museum, two flagship merchandise stores will open in Tsim Sha Tsui and on Hong Kong Island between March and April 2025. Spanning over 3,000 square feet each, these stores will be the first of their kind in the world, offering exclusive Cristiano Ronaldo signed merchandise and memorabilia.

The opening of the Cristiano Ronaldo Museum at K11 MUSEA promises to be a landmark event in Hong Kong’s cultural landscape, offering an unparalleled experience for fans and visitors alike.

The issuer is solely responsible for the content of this announcement.

About Cristiano Ronaldo

Cristiano Ronaldo is a global icon whose influence extends far beyond the football field. Known not only for his unparalleled skills and record-breaking achievements in the sport but also for his leadership, entrepreneurial ventures, and impactful philanthropic efforts, Ronaldo embodies excellence and inspires millions worldwide.

About K11

K11 is a global cultural brand founded in 2008 by renowned entrepreneur Dr Adrian Cheng. The company’s unique and original business model, “Cultural Commerce”, blends culture, art, and commerce to create an ecosystem that caters to all walks of life. With its headquarters in Hong Kong, the Group has expanded its reach and influence, achieving a significant presence across Greater China. Upholding its core values of Art, People, and Nature, the Group aims to democratise art, incubate cultural talents, advocate sustainable development, and inspire the new generations. In addition to its groundbreaking multi-development project in Hong Kong, Victoria Dockside, K11 Art and Cultural District, the Group operates a wide range of businesses, including retail, workplace, hospitality, and luxury residence.

Looking ahead to the future, K11 is expected to attain a footprint of 38 projects with an approximate GFA of 3 million square meters in 12 cities across Greater China upon completion, and it continues setting new standards in “Cultural Commerce”.

VAIO Re-enters the Singapore Market, Debuts New Laptop

SINGAPORE – Media OutReach Newswire – 4 February 2025 – VAIO Corporation (Headquarters: Azumino City, Nagano Prefecture, President & CEO: Masaki Yamano, hereinafter referred to as “VAIO”), today announced its re-entry into the Singapore market through a partnership with Unified-1 Solutions Pte. Ltd. as the official authorised distributor of VAIO products. This strategic initiative reflects VAIO’s commitment to expanding its footprint in Southeast Asia and responding to the growing demand for high-performance computing solutions.

The decision to reestablish operations in Singapore highlights VAIO’s recognition of the market’s unique potential. With its vibrant business ecosystem and strong focus on technological advancement, Singapore serves as an ideal base for VAIO to introduce its latest innovations and engage directly with consumers and businesses, effectively addressing the evolving demands of modern work and lifestyle.

Founded in 1997 as PC brand of Sony Corporation, VAIO established itself as a leader in lightweight and portable laptops and has become synonymous with innovative design and exceptional performance. After becoming an independent entity from Sony in 2014, VAIO has continued to uphold this legacy by focusing on high-quality manufacturing at its head office factory in Azumino City, Nagano Prefecture, located at the foot of the Northern Japan Alps. Today, approximately 90% of VAIO’s sales come from corporate laptops.

Introducing the New Laptop

As part of its re-entry into the market, VAIO is proud to unveil its latest laptop model, the VAIO® SX14-R for consumers and VAIO® Pro PK-R for business users, both sharing the same core design and performance capabilities. At just 1.08kg, the ultra-lightweight carbon fibre SX14-R and Pro PK-R redefine mobile productivity, offering seamless portability for users and professionals on the move.

The SX14-R and Pro PK-R is equipped with advanced features that enhance the user experience for various work environments. Its AI noise-cancelling function utilises multiple microphones to dramatically improve web conferencing capabilities, ensuring clear communication during virtual meetings, regardless of background noise.

In addition to its impressive performance, the SX14-R and Pro PK-R boast a large-capacity battery that supports extended use without frequent recharging, allowing users to stay engaged without disruption. The thoughtfully designed aesthetics elevate the laptop’s visual appeal, with a selection of colours including a unique deep emerald option.

Masaki Yamano, President and CEO of VAIO Corporation, said: “As we embark on this exciting journey in Singapore, we are dedicated to building strong relationships with local businesses and consumers alike. Our innovative features – such as AI noise-cancelling function and user-sensing capabilities – are designed to meet the needs of professionals and businesses prioritising seamless communication and efficiency. VAIO aims to empower users with technology that elevates their dynamic lifestyles and work experiences.”

Customers can experience and purchase the VAIO SX14-R at Best Denki stores, the authorised reseller of VAIO products, located at VivoCity Mall, Ngee Ann City, and upcoming in Funan Mall in March. Discover firsthand the innovative quality and exceptional performance that define VAIO laptops, now available in Singapore.

Our corporate products, such as the VAIO Pro PK-R, are available through our authorised resellers. Kindly find images of the products here. For more information, please visit: https://www.vaio.com.sg/where-to-buy

Hashtag: #VAIO

The issuer is solely responsible for the content of this announcement.

About VAIO

VAIO Corporation, headquartered in Azumino City, Nagano, Japan, was established on July 1, 2014, following a spin-off from Sony’s PC business. With its rich history and product philosophy of being ‘Inspiring,’ ‘Ingenious,’ and ‘Genuine,’ VAIO is committed to delivering exceptional computing experiences and becoming a trusted partner to its users.

For more information about our products and upcoming events, please visit .

About Unified-1 Solutions Pte. Ltd.

Unified 1 Solutions Pte Ltd is the exclusive Distributor and After Sales Provider for VAIO Products in Singapore. We have a team of skilled professionals that is dedicated to the course of establishing excellent customer’s experiences with VAIO Products.